Report #2842973

Overview

Sex

Unknown

Age

Age unknown

State

NM

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

blustery rash on hands and feet with severe pain; blustery rash on hands and feet with severe pain; This non-serious case was reported by a consumer via sales rep and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Shingrix and Arexvy. On an unknown date, an unknown time after receiving Shingrix and Arexvy, the patient experienced rash (Verbatim: blustery rash on hands and feet with severe pain) and pain (Verbatim: blustery rash on hands and feet with severe pain). The outcome of the rash was unknown and the outcome of the pain was not reported. It was unknown if the reporter considered the rash and pain to be related to Shingrix and Arexvy. It was unknown if the company considered the rash and pain to be related to Shingrix and Arexvy. Additional Information: GSK Receipt Date: 21-MAY-2025 The patient was vaccinated with Shingrix and Arexvy at the pharmacy in the same day. The patient later developed a blustery rash on hands and feet with severe pain.; Sender's Comments: US-GSK-US2025063431:same reporter